Skip to main content
●+254 119 023975 support@dnalabskenya.com
Patient Portal LoginB2B / Doctor Portal
DNA LabsKenya
Medical information Clinical review pending

Immunology Testing

Antimog Myelin Oligodendrocyte Glycoprotein CSF Test

This test detects antibodies against myelin oligodendrocyte glycoprotein (MOG) in cerebrospinal fluid (CSF) to help diagnose certain neurological disorders.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
1 mL (0.5 mL minimum) of cerebrospinal fluid (CSF) collected in a sterile screw-capped container.
Results
Report typically available the same day if the sample is collected by 9 AM on Tuesday or Friday. Confirm with the laboratory before booking.
Preparation
No special preparation is required for this test.
Test priceKSh 18,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Antimog Myelin Oligodendrocyte Glycoprotein CSF Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us
01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Unexplained neurological symptoms
  • ✓Suspected inflammatory demyelinating disease
  • ✓Vision problems potentially related to neurological conditions
  • ✓Muscle weakness or coordination difficulties
  • ✓Evaluation of suspected MOG antibody-associated disease (MOGAD)
02

In plain language

What this test helps you understand

This test aids in the diagnosis of inflammatory demyelinating diseases of the central nervous system, particularly those associated with MOG antibodies. It helps differentiate these conditions from other neurological disorders.
The Antimog Myelin Oligodendrocyte Glycoprotein CSF Test is a diagnostic tool used to evaluate disorders of the nervous system. It helps identify specific autoimmune conditions affecting the myelin sheath of neurons. This test measures the presence of antibodies against myelin oligodendrocyte glycoprotein (MOG) in the cerebrospinal fluid (CSF). The presence of these antibodies can indicate inflammatory demyelinating diseases, such as MOG antibody-associated encephalitis. Early diagnosis through this test can lead to better management and improved patient outcomes.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is required for this test.
Sample1 mL (0.5 mL minimum) of cerebrospinal fluid (CSF) collected in a sterile screw-capped container.
MethodologyConfirm with the laboratory before booking.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects MOG antibodies in CSF. Results should be interpreted in the context of the patient's clinical presentation, medical history, and other diagnostic findings. A negative result does not completely rule out MOG-associated disease. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

MOG stands for Myelin Oligodendrocyte Glycoprotein. It is a protein found on the surface of myelin, the protective sheath around nerve fibers in the central nervous system.
Cerebrospinal fluid (CSF) surrounds the brain and spinal cord. Testing CSF allows for the detection of antibodies and other substances related to neurological conditions that may not be present in blood.
A positive result indicates the presence of MOG antibodies in the CSF, which can support a diagnosis of MOG antibody-associated disease. A negative result may help rule out this condition, but interpretation requires clinical context.
The collection of CSF via lumbar puncture can cause some discomfort, but it is generally a well-tolerated procedure performed by a trained medical professional.
The test requires a sample of cerebrospinal fluid (CSF), typically collected through a procedure called a lumbar puncture (spinal tap).
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Hypersensitivity Pneumonitis HP Panel Test

The Hypersensitivity Pneumonitis (HP) Panel Test helps identify specific IgG antibodies related to environmental allergens, aiding in the diagnosis of conditions like hypersensitivity pneumonitis.

Learn more →

Acetylcholine Receptor AChR Binding Antibody Test

This test helps diagnose Myasthenia Gravis by detecting antibodies that interfere with nerve-muscle communication, leading to muscle weakness. Confirm with the laboratory before booking.

Learn more →

ANCA Antineutrophil Cytoplasmic Antibodies IFA Test

The ANCA Antineutrophil Cytoplasmic Antibodies IFA Test helps identify antibodies linked to autoimmune disorders, aiding in early diagnosis and management.

Learn more →

ANCA Antineutrophil Cytoplasmic Antibodies IFA In Dilutions Test

The ANCA Antineutrophil Cytoplasmic Antibodies IFA In Dilutions Test helps detect antibodies associated with autoimmune disorders affecting kidneys and blood vessels. Recommended for individuals with symptoms suggestive of vasculitis or other autoimmune conditions.

Learn more →
Chat on WhatsApp